News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
GlaxoSmithKline (GSK) CEO Confident Investors Will Be Pleased With Pipeline on Nov. R&D Day     7/30/2015
Progenics Pharmaceuticals, Inc. (PGNX) Announces Breakthrough Therapy Designation for Azedra in Pheochromocytoma And Paraganglioma     7/28/2015
Embattled Vitae Pharma (VTAE) and Boehringer Ingelheim Relationship Takes Another Blow, Drops BACE Inhibitor Program for Alzheimer’s     7/27/2015
Cara Therapeutics, Inc. (CARA) Soars 35% on Positive Phase II Uremic Pruritus Data     7/23/2015
Amgen (AMGN) Lauds Positive Phase II Data for Leukemia Drug Blincyto     7/17/2015
Zogenix (ZGNX) and FDA Delay Two Rare Epilepsy Trials by Three Months     7/15/2015
Genentech (RHHBY)’s Breakthrough Atezolizumab Joins Club of Successful Anti-PD-L1 Drugs, Shrinks Tumors in Bladder Cancer     7/14/2015
BIO2015 EXCLUSIVE: BioSpace (DHX)’s Insider Profile of Neovacs SA     7/9/2015
EXCLUSIVE: DNAnexus, Stanford University Genomic Catalog Will Accelerate Science in the Field, Says CEO     7/8/2015
Evotec AG (EVTG.F), Roche (RHHBY)'s Alzheimer's Hopeful Fails Another Trial     7/2/2015
EXCLUSIVE: Pediatric Patients Could Benefit Most From New Oncoceutics Cancer Drug, Says Exec     7/2/2015
Vitae Pharma (VTAE)’ Diabetes Drug Fails Mid-Stage Trial, the Second Drug in Less Than Six Months to Fail     6/29/2015
Aquinox (AQXP)’s Bladder Pain Drug Fails to Meet Statistical Endpoint in Phase II Trial     6/25/2015
Vical  (VICL) Herpes Vaccine Clinical Trial Disappoints with "Confounding Results"     6/24/2015
Alcobra (ADHD)’s Fragile X Syndrome Drug Fails During Mid-Stage Trial     6/24/2015

Featured Stories
Why Investors Shouldn't Freak Out Over Vertex (VRTX)'s Latest Trial Results     3/24/2015
Newcomers Like Aerie Pharmaceuticals, Inc. (AERI), Inotek Pharmaceuticals Corporation Aim to Shake Up Big Pharma With New Wave of Glaucoma Drugs     2/10/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Retrenches, And Searches For Answers, After Failed Trial     5/22/2014
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research?     4/4/2014
Popular Weight-Lifting Supplement May Slow Huntington Disease, Massachusetts General Hospital Study     2/11/2014
Dawn of A New Sleep Drug at Merck & Co., Inc. (MRK)?     7/19/2011
Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study     1/28/2011
Experimental Drug Panobinostat Shows Little Activity In MDS Patients, Sarah Cannon Research Institute Study     12/30/2010
Cytokinetics, Inc. (CYTK) Drug Helps ALS Patients in Small Trial     12/13/2010
American Society of Hematology: Novel Hodgkin Drug 'Dramatic' in Refractory Patients, City of Hope Study     12/7/2010
American College of Rheumatology: Anti-IL17 Drug Misses Endpoint in RA Trial, Stanford University Study     11/11/2010
American Association for Study of Liver Diseases: Early Study Shows HCV Vaccine Works, Scripps Clinic Study     11/3/2010
American Association for Study of Liver Diseases: Rapid Response for Once-Daily Protease Inhibitor, University of North Carolina Study     11/3/2010
American Academy of Ophthalmology: Glaucoma Drug Passes Early Clinical Test     10/21/2010
Ceregene, Inc. Initiates a New Controlled Phase 2b Trial of Cere-120 for Parkinson's Disease     10/19/2010
Immunomedics, Inc. (IMMU) Announces Orphan Drug Designation For Veltuzumab For The Treatment Of Immune Thrombocytopenia     8/4/2015
Allena Pharmaceuticals, Inc. Initiates Phase IIb Trial Of ALLN-177 For Secondary Hyperoxaluria     8/4/2015
Celgene (CELG) Exercises Early Option To Exclusively License GI-6207, A Novel Cancer Immunotherapy     8/4/2015
Incyte (INCY) Reports 2015 Second-Quarter Financial Results And Updates Shareholders On Key Clinical Programs     8/4/2015
Juniper Pharmaceuticals Reports Second Quarter 2015 Financial Results     8/4/2015
Nivalis Therapeutics Reports Financial Results For The Second Quarter 2015     8/4/2015
Ocular Therapeutix (OCUL) To Report Second Quarter 2015 Financial Results     8/4/2015
Versartis, Inc. (VSAR) Reports Second Quarter 2015 Financial Results     8/4/2015
Independent Results Show That BiondVax Pharmaceuticals's Universal Flu Vaccine Administered In A Trial 3 Years Ago Improves Immunogenicity Against Current Flu H3N2 Epidemic     8/3/2015
TWi Pharmaceuticals, Inc. Release: Twi Biotechnology Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 For The Indication Of Type II Diabetes In Europe And Russia     8/3/2015
CytRx Corporation (CYTR) Reports 2015 Second Quarter Financial Results     8/3/2015
PTC Therapeutics (PTCT) Reports Second Quarter 2015 Financial Results And Provides Corporate Update     8/3/2015
Threshold Pharmaceuticals, Inc. (THLD) Reports Second Quarter 2015 Financial And Operational Results     8/3/2015
Novavax, Inc. (NVAX) Announces Positive Data From Phase II Trial Of Quadrivalent Seasonal Influenza VLP     7/30/2015
Galapagos (GLPG.BR)' Selective JAK1 Inhibitor Filgotinib Meets Key Efficacy Endpoints, Shows ACR70 Responses Up To 39%, And Maintains Safety Profile After 24 Weeks Of Treatment In DARWIN 1 Phase 2B Study     7/30/2015

More News
No News Posted on that date

Career Tips
5 Life Science Companies You Definitely Want to Work For     7/23/2015
What Makes Hiring Managers Think They've Found the One     7/9/2015
"War On Talent" Heating Up in the Bay, Boehringer Ingelheim Exec Tells BioSpace     7/9/2015
5 Ways to Make Your Cover Letter Pop, Not Flop     7/9/2015
CombiMatrix (CBMX) Will Nearly Double Staff in 2015 As Hiring Roars, CEO Says     6/25/2015
3 Skills You Need to Succeed in the Biotech Industry     6/25/2015
5 Hiring Tricks Revealed     6/25/2015
Northern California Readies for Talent Connect As Biotech Bay Booms     6/15/2015
3 Unexpected New Ways to Revamp Your Resume     6/11/2015
Radius Health (RDUS) Plans to Double Staff in 2015, Exec Tells BioSpace (DHX)     6/11/2015
The Most Exciting Companies in Biotech     6/1/2015
Corbus Will Interview Twice as Many Candidates in 2015 as Its Ranks Grow     5/29/2015
HR Exec Says Alder Biopharma Will Grow 30% in 2015, As Hunt for Candidates Continues     5/15/2015
The After-Interview Trick You’re Not Using     5/14/2015
New Networking Opportunities at Talent Connect, Over 600 Bioscience Jobs Available Now     5/14/2015

Other News Sources
//-->